Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165,952 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.
Zhong YM, Yin K, Chen Y, Xie Z, Lv ZY, Yang JJ, Yang XN, Zhou Q, Wang BC, Zhong WZ, Gao LL, Zhou WB, Chen J, Tu HY, Liao RQ, Zhang DK, Zhang SL, Lu DX, Zheng HB, Zhang HH, Wu YL, Zhang XC. Zhong YM, et al. Among authors: chen j, chen y. Front Immunol. 2022 Oct 3;13:951817. doi: 10.3389/fimmu.2022.951817. eCollection 2022. Front Immunol. 2022. PMID: 36263036 Free PMC article.
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer.
Feng HB, Chen Y, Xie Z, Jiang J, Zhong YM, Guo WB, Yan WQ, Lv ZY, Lu DX, Liang HL, Xu FP, Yang JJ, Yang XN, Zhou Q, Zhang DK, Zhang Z, Chuai SK, Zhang HH, Wu YL, Zhang XC. Feng HB, et al. Among authors: chen y. Thorac Cancer. 2021 Oct;12(19):2564-2573. doi: 10.1111/1759-7714.14137. Epub 2021 Sep 6. Thorac Cancer. 2021. PMID: 34490728 Free PMC article.
An integrated biomarker of PD-L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases.
Li LL, Zhou DX, Lu M, Zhou D, Lin XF, Chen Y, Yin K, Feng HB, Guo WB, Xie Z, Yan WQ, Lv ZY, Lu DX, Zhang SL, Zhang XC. Li LL, et al. Among authors: chen y. Thorac Cancer. 2022 Jul;13(13):1948-1960. doi: 10.1111/1759-7714.14473. Epub 2022 May 20. Thorac Cancer. 2022. PMID: 35596539 Free PMC article.
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non-Small Cell Lung Cancer.
Zhang JT, Liu SY, Gao W, Liu SM, Yan HH, Ji L, Chen Y, Gong Y, Lu HL, Lin JT, Yin K, Jiang BY, Nie Q, Liao RQ, Dong S, Guan Y, Dai P, Zhang XC, Yang JJ, Tu HY, Xia X, Yi X, Zhou Q, Zhong WZ, Yang XN, Wu YL. Zhang JT, et al. Among authors: chen y. Cancer Discov. 2022 Jul 6;12(7):1690-1701. doi: 10.1158/2159-8290.CD-21-1486. Cancer Discov. 2022. PMID: 35543554 Free PMC article.
Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+ CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer.
Liang H, Li H, Xie Z, Jin T, Chen Y, Lv Z, Tan X, Li J, Han G, He W, Qiu N, Jiang M, Zhou J, Xia H, Zhan Y, Cui L, Guo W, Huang J, Zhang X, Wu YL. Liang H, et al. Among authors: chen y. Thorac Cancer. 2020 Oct;11(10):2941-2954. doi: 10.1111/1759-7714.13639. Epub 2020 Sep 7. Thorac Cancer. 2020. PMID: 32894006 Free PMC article.
165,952 results
You have reached the last available page of results. Please see the User Guide for more information.